HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of Aroclor 1260 exposure in a mouse model of diet-induced obesity and non-alcoholic fatty liver disease.

Abstract
Polychlorinated biphenyls (PCBs) are persistent organic pollutants associated with non-alcoholic fatty liver disease (NAFLD) in epidemiologic studies. The purpose of this study was to evaluate the hepatic effects of a PCB mixture, Aroclor 1260, whose composition mimics human bioaccumulation patterns, in a mouse model of diet-induced obesity (DIO). Male C57Bl/6J mice were fed control diet or 42% high fat diet (HFD) and exposed to Aroclor 1260 (20mg/kg or 200mg/kg in corn oil) for 12weeks. A glucose tolerance test was performed; plasma/tissues were obtained at necropsy for measurements of adipocytokine levels, histology, and gene expression. Aroclor 1260 exposure was associated with decreased body fat in HFD-fed mice but had no effect on blood glucose/lipid levels. Paradoxically, Aroclor 1260+HFD co-exposed mice demonstrated increased hepatic inflammatory foci at both doses while the degree of steatosis did not change. Serum cytokines, ALT levels and hepatic expression of IL-6 and TNFα were increased only at 20mg/kg, suggesting an inhibition of pro-inflammatory cytokine production at the 200mg/kg exposure. Aroclor 1260 induced hepatic expression of cytochrome P450s including Cyp3a11 (Pregnane-Xenobiotic Receptor target) and Cyp2b10 (constitutive androstane receptor target) but Cyp2b10 inducibility was diminished with HFD-feeding. Cyp1a2 (aryl hydrocarbon Receptor target) was induced only at 200mg/kg. In summary, Aroclor 1260 worsened hepatic and systemic inflammation in DIO. The results indicated a bimodal response of PCB-diet interactions in the context of inflammation which could potentially be explained by xenobiotic receptor activation. Thus, PCB exposure may be a relevant "second hit" in the transformation of steatosis to steatohepatitis.
AuthorsBanrida Wahlang, Ming Song, Juliane I Beier, K Cameron Falkner, Laila Al-Eryani, Heather B Clair, Russell A Prough, Tanasa S Osborne, David E Malarkey, J Christopher States, Matthew C Cave
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 279 Issue 3 Pg. 380-390 (Sep 15 2014) ISSN: 1096-0333 [Electronic] United States
PMID24998970 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014. Published by Elsevier Inc.
Chemical References
  • Adipokines
  • Aroclors
  • Blood Glucose
  • Environmental Pollutants
  • Membrane Proteins
  • Receptors, Aryl Hydrocarbon
  • Toll-Like Receptor 4
  • Triglycerides
  • aroclor 1260
  • Cholesterol
  • Steroid Hydroxylases
  • Aryl Hydrocarbon Hydroxylases
  • Cyp2b10 protein, mouse
  • Cyp3a11 protein, mouse
  • Cytochrome P-450 CYP3A
  • Cytochrome P450 Family 2
Topics
  • Adipokines (metabolism)
  • Adipose Tissue (pathology)
  • Animals
  • Aroclors (toxicity)
  • Aryl Hydrocarbon Hydroxylases (biosynthesis, genetics)
  • Blood Glucose (metabolism)
  • Cholesterol (metabolism)
  • Cytochrome P-450 CYP3A (biosynthesis, genetics)
  • Cytochrome P450 Family 2
  • Diet
  • Environmental Pollutants (toxicity)
  • Fatty Liver (chemically induced, pathology)
  • Gene Expression (drug effects)
  • Glucose Tolerance Test
  • Inflammation (chemically induced, pathology)
  • Liver (pathology)
  • Membrane Proteins (biosynthesis, genetics)
  • Mice
  • Mice, Inbred C57BL
  • Non-alcoholic Fatty Liver Disease
  • Obesity (chemically induced, pathology)
  • Real-Time Polymerase Chain Reaction
  • Receptors, Aryl Hydrocarbon (biosynthesis, genetics)
  • Steroid Hydroxylases (biosynthesis, genetics)
  • Toll-Like Receptor 4 (biosynthesis, genetics)
  • Triglycerides (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: